PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY. Вопр. онкол. [Internet]. 2020 Jan. 1 [cited 2026 Oct. 14];66(1):23-8. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1051